SOLICITATION NOTICE
65 -- Acquisition of cGMP-grade GS-441524 for the Treatment of COVID-19
- Notice Date
- 2/1/2022 11:50:09 AM
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 325412
— Pharmaceutical Preparation Manufacturing
- Contracting Office
- NATIONAL INSTITUTES OF HEALTH NIDA Bethesda MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- 75N95022Q00102
- Response Due
- 2/7/2022 6:00:00 AM
- Archive Date
- 02/08/2022
- Point of Contact
- Kimberly Espinosa, Phone: 301-827-3546
- E-Mail Address
-
kimberly.espinosa@nih.gov
(kimberly.espinosa@nih.gov)
- Description
- THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to Avisa Pharma Solutions, Inc. (dba Cambrex), 3501 Tricenter Blvd Ste C, Durham, NC� 27713-1868. To ensure consistency among material, the current requirement must be manufactured by the same vendor that is manufacturing the non-GMP material for the same project under Contract No. 75N95021P00063. Therefore, this acquisition is restricted to Avisa Pharma Solutions, Inc. (dba Cambrex). The purpose of this acquisition is to obtain 2-3Kg of cGMP GS-441524. See attachments for complete requirement details.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/a509948806dd4ec197bcfd82ad154320/view)
- Record
- SN06230306-F 20220203/220201230114 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |